Suppr超能文献

针对高剂量率同步微束放射治疗的神经肿瘤临床试验:首例自发性犬脑肿瘤治疗。

Toward Neuro-Oncologic Clinical Trials of High-Dose-Rate Synchrotron Microbeam Radiation Therapy: First Treatment of a Spontaneous Canine Brain Tumor.

机构信息

Université Grenoble Alpes, Institut National de la Santé et de la Recherche Médicale UA7 Synchrotron Radiation for Biomedicine, Saint-Martin d'Hères, France; Centre Hospitalier Universitaire Grenoble Alpes, Maquis du Grésivaudan, La Tronche, France.

European Synchrotron Radiation Facility, Grenoble, France.

出版信息

Int J Radiat Oncol Biol Phys. 2022 Aug 1;113(5):967-973. doi: 10.1016/j.ijrobp.2022.04.022. Epub 2022 Apr 26.

Abstract

PURPOSE

The high potential of microbeam radiation therapy (MRT) in improving tumor control while reducing side effects has been shown by numerous preclinical studies. MRT offers a widened therapeutic window by using the periodical spatial fractionation of synchrotron generated x-rays into an array of intense parallel microbeams. MRT now enters a clinical transfer phase. As proof of principle and cornerstone for the safe clinical transfer of MRT, we conducted a "first in dog" trial under clinical conditions. In this report, we evaluated whether a 3-dimensional conformal MRT can be safely delivered as exclusive radiosurgical treatment in animal patients METHODS AND MATERIALS: We irradiated a 17.5-kg French bulldog for a spontaneous brain tumor (glioma suspected on magnetic resonance imaging) with conformal high-dose-rate microbeam arrays (50-µm-wide microbeams, replicated with a pitch of 400 μm) of synchrotron-generated x-rays. The dose prescription adjusted a minimal cumulated valley dose of 2.8 Gy to the plnning target volume (PTV) (cinical target volume (CTV)+ 1 mm). Thus, each beam delivered 20 to 25 Gy to the target as peak doses, and ∼1 Gy as valley doses RESULTS: The treatment was successfully delivered. Clinical follow-up over 3 months showed a significant improvement of the dog's quality of life: the symptoms disappeared. Magnetic resonance imaging, performed 3 months after irradiation, revealed reduction in tumor size (-87.4%) and mass effect with normalization of the left lateral ventricle.

CONCLUSIONS

To our knowledge, this neuro-oncologic veterinary trial is the first 3-dimensional conformal synchrotron x-ray MRT treatment of a spontaneous intracranial tumor in a large animal. It is an essential last step toward the clinical transfer of MRT in the near future to demonstrate the feasibility and safety of treating deep-seated tumors using synchrotron-generated microbeams.

摘要

目的

大量的临床前研究表明,微束放射治疗(MRT)在提高肿瘤控制率的同时降低副作用方面具有巨大潜力。MRT 通过周期性地将同步加速器产生的 X 射线分割成密集平行的微束来扩大治疗窗口。MRT 现在进入临床转化阶段。作为 MRT 安全临床转化的原理证明和基石,我们在临床条件下进行了首例犬科动物试验。在本报告中,我们评估了 3 维适形 MRT 是否可以作为一种单独的放射外科治疗方法,在动物患者中安全实施。

方法和材料

我们用适形高剂量率微束阵列(50 μm 宽的微束,以 400 μm 的间距重复)对一只 17.5 公斤的法国斗牛犬进行了自发性脑肿瘤(磁共振成像怀疑为胶质瘤)的照射。剂量方案将最小累积谷剂量 2.8 Gy 调整到计划靶区(PTV)(临床靶区(CTV)+1 mm)。因此,每个射束以峰值剂量向靶区输送 20 到 25 Gy,以谷剂量输送约 1 Gy。

结果

治疗成功实施。3 个月的临床随访显示狗的生活质量显著改善:症状消失。照射 3 个月后进行的磁共振成像显示肿瘤体积缩小(-87.4%)和质量效应减轻,左侧侧脑室正常化。

结论

据我们所知,这是首例在大型动物中对自发性颅内肿瘤进行的 3 维适形同步加速器 X 射线 MRT 治疗的神经肿瘤学兽医试验。这是在不久的将来将 MRT 临床转化为治疗深部肿瘤的可行性和安全性的最后关键步骤,使用同步加速器产生的微束。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验